MMED
MINIMED GRP (MMED)
NASDAQ
$18.31+$0.02 (+0.11%)
Price as of Oct 22, 2026 7:47 PM EDT
  • $5.0B
    Market Cap
  • N/A
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
04/24/2026
Income Statement
Total Operating Revenue
3.1B
N/A
Cost of Revenue
1.4B
N/A
Gross Profit
1.7B
N/A
Sales and Marketing Expense
1.2B
N/A
Research and Development Expense
-448.0M
N/A
Depreciation and Amortization Expense
156.0M
N/A
Total Operating Expenses
1.4B
N/A
Operating Profit
-190.0M
N/A
Interest Income
N/A
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
0
N/A
Total Nonoperating Income and Expense
1.0M
N/A
Income before Taxes
-189.0M
N/A
Income Taxes
128.0M
N/A
Extraordinary Items
84.0M
N/A
Net Income
-333.0M
N/A
Net Income from Continuing Operations Applicable to Common
-189.0M
N/A
Basic EPS and Net Income
-1.30
N/A
Diluted EPS and Net Income
-1.30
N/A
Basic Weighted Average Shares
256.6M
N/A
Diluted Weighted Average Shares
256.6M
N/A
Balance Sheet
Cash and Cash Equivalents
298.0M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
298.0M
N/A
Total Current Assets
1.3B
N/A
Accumulated Depreciation
781.0M
N/A
Property and Plant and Equipment and Net
711.0M
N/A
Total Long-Term Assets
147.0M
N/A
Total Assets
4.6B
N/A
Income Taxes Payable
38.0M
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
702.0M
N/A
Total Long-Term Debt
0
N/A
Total Long-Term Liabilities
317.0M
N/A
Total Liabilities
1.0B
N/A
Retained Earnings
-116.0M
N/A
Total Stockholders Equity
3.6B
N/A
Total Shares Outstanding
280.8M
N/A
Cash Flow
Cash from Operating Activities
-197.0M
N/A
Capital Expenditures
223.0M
N/A
Cash from Investing Activities
-233.0M
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
716.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow